Getinge Group: Getinge Interim Report January-September 2016

GETINGE, Sweden--()--Regulatory News:

Getinge Group (STO:GETIB)

Third quarter of 2016 in brief

· Order intake decreased 3.0% to SEK 7,176 M (7,397). The order intake declined organically by 3.2%.

· Net sales increased 0.1% to SEK 6,929 M (6,925). Net sales increased organically by 0.2%.

· Gross margin increased to 47.3% (46.8).

· EBITA* improved 16.3% to SEK 963 M (828).

· Restructuring costs increased to SEK 732 M (213). SEK 628 M comprises a provision for the FDA-related remediation program, write-down of an R&D project and costs for changes among senior executives.

· Profit before tax decreased 146.2% to SEK -110 M (238), due to increased restructuring costs.

· Earnings per share decreased to SEK -0.36 (0.73).

· Good cost control as a consequence of the efficiency-enhancement program, Big 5.

· Changes to Getinge Executive Team, Acting CEO, new CFO and HR Director.

· FDA update, SEK 400 M provision related to the remediation program.

· Changed outlook, moderately negative sales growth for the full year.

· Key event after the reporting period, further developed and focused strategy, and preparation for distribution of Patient & Post-Acute Care to shareholders of Getinge.

January-September 2016 in brief

· Order intake decreased 2.5% to SEK 21,560 M (22,105). The order intake fell organically by 0.7%.

· Net sales decreased 2.8% to SEK 20,233 M (20,818). Net sales fell organically by 1.1%.

· Gross margin amounted to 46.7% (46.7).

· EBITA* improved 4.9% to SEK 2,371 M (2,260).

· Restructuring costs increased to SEK 992 M (483).

· Profit before tax decreased 42.8% to SEK 358 M (626).

· Earnings per share decreased to SEK 1.03 (1.81).

Financial summary

MSEK  

Q3 2016

  Q3 2015   Change %  

Jan-Sep 2016

  Jan-Sep 2015   Change %   FY 2015
Order intake

7 176

7 397 -3.00%

21 560

22 105 -2.50% 30 431
Net sales

6 929

6 925 0.10%

20 233

20 818 -2.80% 30 235
Gross Profit

3 275

3 240 1.10%

9 453

9 713 -2.70% 14 163
Gross margin

47.30%

46.80% 0.50%

46.70%

46.70% 0.00% 46.80%
EBITA*

963

828 16.30%

2 371

2 260 4.90% 4 179
EBITA margin*

13.90%

12.00% 1.90%

11.70%

10.90% 0.80% 13.80%
Operating profit

49

421 -88.40%

838

1 184 -29.20% 2 729
Profit before tax

-110

238 -146.20%

358

626 -42.80% 1 997
Net profit

-81

174 -146.60%

261

457 -42.90% 1 457
Earnings per share, SEK

-0.36

0.73 -149.30%

1.03

1.81 -43.10% 5.83
Cash flow from operations

725

724 0.10%

1 888

1 974 -4.40% 3 458

* before restructuring, acquisition and integration cost

Getinge Group is a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. Getinge’s unique customer offering mirrors the hospital’s organization and value chain, and the solutions are used before, during and after the patients’ hospital stay. Based on first-hand experience and close partnerships, Getinge provides innovative healthcare solutions that improve every-day life for people, today and tomorrow.

This information is information that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 13:00 p.m. CET on October 18, 2016

This information was brought to you by Cision http://news.cision.com

Contacts

Getinge Group
Kornelia Rasmussen
Executive Vice President Group Communications
Phone: +46 (0)10 335 58 10
E-mail: kornelia.rasmussen@getinge.com

Contacts

Getinge Group
Kornelia Rasmussen
Executive Vice President Group Communications
Phone: +46 (0)10 335 58 10
E-mail: kornelia.rasmussen@getinge.com